LEXARIA BIOSCIENCE CORP. Option Indexed to Issuer's Equity, Strike Price
LEXARIA BIOSCIENCE CORP. (LEXX) reported Option Indexed to Issuer's Equity, Strike Price of $2.93 per share for the 9-month period ending 2024-05-31, per its 10-Q filed 2024-07-12.
Discontinued › Notes › Other Liabilities
us-gaap:OptionIndexedToIssuersEquityStrikePrice1 · last filed 2024-07-12
- LEXARIA BIOSCIENCE CORP. option indexed to issuer's equity, strike price for the quarter ending 2023-11-30 was $3.27.
- LEXARIA BIOSCIENCE CORP. option indexed to issuer's equity, strike price for fiscal 2021 was $7.08.
| Period end | Option Indexed to Issuer's Equity, Strike Price 3 month | Option Indexed to Issuer's Equity, Strike Price 6 month | Option Indexed to Issuer's Equity, Strike Price 9 month | Option Indexed to Issuer's Equity, Strike Price 12 month |
|---|---|---|---|---|
| 2024-05-31 | $2.93 10-Q · filed 2024-07-12 | |||
| 2024-02-29 | $3.27 10-Q · filed 2024-04-09 | |||
| 2023-11-30 | $3.27 10-Q · filed 2024-01-12 | |||
| 2023-05-31 | $3.27 10-Q · filed 2023-07-14 | |||
| 2023-02-28 | $4.40 10-Q · filed 2023-04-14 | |||
| 2021-08-31 | $7.08 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |